Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03304132 · ClinicalTrials.gov registry record
The Oral Microbiome and Upper Aerodigestive Squamous Cell Cancer
A clinical trial, sponsored by NYU Langone Health.
- Completed
- Registry status
- 560
- Enrollment target
NCT03304132 is a clinical trial that has completed, run by NYU Langone Health. The registered enrollment target is 560 participants.
The verdict
NCT03304132 has completed, sponsored by NYU Langone Health.
- COMPLETED
- Registry status
- 560 participants
- Enrollment target
Study Summary
The human oral cavity is a diverse habitat that contains approximately 700 prokaryotic species. The oral microbiome is comprised of 44% named species, 12% isolates representing unnamed species, and 44% phylotypes known only from 16S rRNA based cloning studies (http://www.homd.org/). Species from 11 phyla have been identified: Firmicutes, Bacteroidetes, Proteobacteria, Actinobacteria, Spirochaetes, Fusobacteria, TM7, Synergistetes, Chlamydiae, Chloroflexi and SR1 (http://www.homd.org/). Because these observations have been mainly based on data generated from traditional Sanger sequencing, the diversity of oral microbiome is highly likely underestimated. Application of high throughput sequencing to the oral microbiome similar to the scale of the microbiome studies of other body sites (GI tract, skin, and vagina) under the Human Microbiome Project is necessary to obtain data essential for understanding the diversity and community structure of the oral microbiome in health and disease.
Interventions
- OTHER Classification of Oral Microbiome Using 16S rRNA gene sequence-based approach
- OTHER Classification of Oral Microbiome Using taxonomic approach
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 560 participants |
| Start Date | 1992-12-01 |
| Est. Completion | 2010-12-01 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03304132
The ClinicalTrials.gov registry entry for NCT03304132 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 560 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is NYU Langone Health, which has 1,164 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Classification of Oral Microbiome Using 16S rRNA gene sequence-based approach is the first listed.
NCT03304132 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03304132 about?
NCT03304132 is a clinical study titled "The Oral Microbiome and Upper Aerodigestive Squamous Cell Cancer". The human oral cavity is a diverse habitat that contains approximately 700 prokaryotic species. The oral microbiome is comprised of 44% named species, 12% isolates representing unnamed species, and 44% phylotypes known only from 16S rRNA based cloning studies (http://www.homd.org/). Species from 11 ...
What is the current status of trial NCT03304132?
This trial is currently completed. The enrollment target is 560 participants. The study started on 1992-12-01. Estimated completion is 2010-12-01.
What interventions are being tested in trial NCT03304132?
The interventions under investigation include: Classification of Oral Microbiome Using 16S rRNA gene sequence-based approach (OTHER), Classification of Oral Microbiome Using taxonomic approach (OTHER).
Who is sponsoring clinical trial NCT03304132?
This trial is sponsored by NYU Langone Health, which has 1,164 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.